📰 Card Fail News
Page 2 - Card Fail News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Card Fail. Real-time updates on events, politics, business and more.
June 9, 2022
/PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), today announced the closing of a $54 million...
April 1, 2022
Landmark trial advances understanding of which HFpEF patients may benefit from atrial shunt therapy TEWKSBURY, Mass., April 1, 2022 /PRNewswire/ -- Corvia Medical, Inc, a company
April 1, 2022
/PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), announced publication of analyses from its...
February 1, 2022
REDUCE LAP-HF II study defines treatable HFpEF patient population for atrial shunt therapy TEWKSBURY, Mass., Feb. 1, 2022 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming
February 1, 2022
/PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), today announced results from its REDUCE LAP-HF II...
February 1, 2022
TEWKSBURY, Mass., Feb. 1, 2022 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), today...
October 15, 2021
The acquisition of global rights for a novel heart failure drug could help millions of people A European biopharma company has acquired the global
April 1, 2021
email article Spurred by great enthusiasm for the latest treatments for heart failure, some groups are putting greater emphasis on clearly defining what exactly heart failure is, and how to communicate it to patients without demoralizing them. There are now five classes of life-saving heart failure drugs, as angiotensin receptor-neprilysin inhibitors and SGLT2 inhibitors were added to heart failure treatment algorithms in new guidance from the American College of Cardiology (ACC). This is...
March 2, 2021
email article An international committee proposed a universal definition for heart failure (HF) and two standard classifications that go beyond reduced and preserved left ventricular ejection fraction (LVEF). "HF is a clinical syndrome with symptoms and or signs caused by a structural and or functional cardiac abnormality and corroborated by elevated natriuretic peptide levels and or objective evidence of pulmonary or systemic congestion," according to the consensus document from the Hear...